KRAS G12C inhibitors and methods of using the same
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Amgen Inc.
A A A C A C C C
A61K A61K A61P C07D A61K C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional
Jian Jeffrey Aaron C. Victor J. Ning Alexander J. Michael J. Patricia Albert Hui-Ling Anthony B. Thomas T. Brian Alan Qiufen Mary Jonathan D. Nobuko Ryan Paul Nuria A. Clifford Shon Longbin Vu Van Jennifer Rebecca John Gordon David John Youngsook Ana Elena Christopher M.
Chen Siegmund Cee Chen Pickrell Frohn Lopez Amegadzie Wang Reed Nguyen Lanman Xue Walton Low Nishimura Wurz Tamayo Goodman Booker Liu Ma Allen Allen Kopecky Shin Minatti Tegley